Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
October 09, 2026 1.355
October 08, 2026 1.342
October 07, 2026 1.375
October 06, 2026 1.362
October 05, 2026 1.328
October 02, 2026 1.388
October 01, 2026 1.355
September 30, 2026 1.388
September 29, 2026 1.335
September 28, 2026 1.342
September 25, 2026 1.355
September 24, 2026 1.401
September 23, 2026 1.368
September 22, 2026 1.415
September 21, 2026 1.408
September 18, 2026 1.385
September 17, 2026 1.375
September 16, 2026 1.342
September 15, 2026 1.322
September 14, 2026 1.328
September 11, 2026 1.348
September 10, 2026 1.362
September 09, 2026 1.328
September 08, 2026 1.335
September 04, 2026 1.342
Date Value
September 03, 2026 1.315
September 02, 2026 1.335
September 01, 2026 1.382
August 31, 2026 1.408
August 28, 2026 1.375
August 27, 2026 1.348
August 26, 2026 1.388
August 25, 2026 1.448
August 24, 2026 1.448
August 21, 2026 1.421
August 20, 2026 1.395
August 19, 2026 1.322
August 18, 2026 1.282
August 17, 2026 1.295
August 14, 2026 1.302
August 13, 2026 1.335
August 12, 2026 1.342
August 11, 2026 1.322
August 10, 2026 1.335
August 07, 2026 1.375
August 06, 2026 1.328
August 05, 2026 1.328
August 04, 2026 1.282
August 03, 2026 1.395
July 31, 2026 1.355

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Myriad Genetics, Inc. 1.356
BioRestorative Therapies, Inc. 0.8042
CareDx, Inc. 7.702
Natera, Inc. 31.59
Exagen, Inc. 16.68

Price to Book Value Related Metrics

PS Ratio 1458.90
Price 2.04
Earnings Yield -32.53%
Market Cap 80.45M